16 February 2021
McCann FitzGerald Advises Mainstay Medical Holdings plc on an Equity Financing
We acted for our client, Mainstay Medical Holdings plc, on an equity financing that raised gross proceeds of US$108 million.
Mainstay intends to use the funds to support the company’s commercial launch of ReActiv8® in the U.S., continued expansion in Europe and Australia, additional post-market clinical studies and research, and general operations. The financing was co-led by new investors Ally Bridge Group and Sofinnova Partners, through its Crossover Fund, and also included a large, global medical device company.
Select how you would like to share using the options below